Eric M. Dube - Jan 24, 2023 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Stock symbol
TVTX
Transactions as of
Jan 24, 2023
Transactions value $
-$138,503
Form type
4
Date filed
1/26/2023, 03:05 PM
Previous filing
Jan 6, 2023
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale -$139K -6.44K -4.18% $21.50 148K Jan 24, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.